Actualité

Names and indications of antibodies facing regulations and pharmaceutical company practices

  • Recherche,
  • Santé-Sciences-Technologie,
  • Santé-social,
Date(s)

le 19 février 2020

Published in Med Sci

Projet de recherche collaborative dirigé par le Prof. D. Antier

Names and indications of antibodies facing regulations and pharmaceutical company practices

Abstract

The names and therapeutic indications of monoclonal antibodies must comply with current regulations, which does not prevent the development of commercial strategies around trade names. Some of these practices are based on territorial or legal considerations while others are motivated by real medical concerns. Finally, some of these have a significant financial impact on the community.

© 2019 médecine/sciences – Inserm

Keywords

#Tours #iBrain #UMR1253 #antibodies #regulations #pharmacy #company

Contact :
Prof. Daniel Antier :